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Abstract
Background
Pregnancy incidence rates among women living with HIV (WLWH) have increased over
time due to longer life expectancy, improved health status, and improved access to and HIV
prevention benefits of combination antiretroviral therapy (cART). However, it is unclear
whether intended or unintended pregnancies are contributing to observed increases.
Methods
We analyzed retrospective data from the Canadian HIV Women’s Sexual and Reproductive
Health Cohort Study (CHIWOS). Kaplan-Meier methods and GEE Poisson models were
used to measure cumulative incidence and incidence rate of pregnancy after HIV diagnosis
overall, and by pregnancy intention. We used multivariable logistic regression models to
examine independent correlates of unintended pregnancy among the most recent/current
pregnancy.
Results
Of 1,165 WLWH included in this analysis, 278 (23.9%) women reported 492 pregnancies
after HIV diagnosis, 60.8% of which were unintended. Unintended pregnancy incidence
(24.6 per 1,000 Women-Years (WYs); 95% CI: 21.0, 28.7) was higher than intended preg-
nancy incidence (16.6 per 1,000 WYs; 95% CI: 13.8, 20.1) (Rate Ratio: 1.5, 95% CI: 1.2–
1.8). Pregnancy incidence among WLWH who initiated cART before or during pregnancy
(29.1 per 1000 WYs with 95% CI: 25.1, 33.8) was higher than among WLWH not on cART
during pregnancy (11.9 per 1000 WYs; 95% CI: 9.5, 14.9) (Rate Ratio: 2.4, 95% CI: 2.0–3.0).
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Women with current or recent unintended pregnancy (vs. intended pregnancy) had higher
adjusted odds of being single (AOR: 1.94; 95% CI: 1.10, 3.42), younger at time of conception
(AOR: 0.95 per year increase, 95% CI: 0.90, 0.99), and being born in Canada (AOR: 2.76,
95% CI: 1.55, 4.92).
Conclusion
Nearly one-quarter of women reported pregnancy after HIV diagnosis, with 61% of all preg-
nancies reported as unintended. Integrated HIV and reproductive health care programming
is required to better support WLWH to optimize pregnancy planning and outcomes and to
prevent unintended pregnancy.
Introduction
Health and survival outcomes for people living with HIV have improved dramatically since
the advent of combination antiretroviral therapy (cART) [1–3]. HIV treatment with sustained
viral suppression is also enabling safer reproductive options for women living with HIV
(WLWH), including better maternal health, improved fertility [4], negligible risk of HIV trans-
mission to partners during condomless sex [5–7], and dramatic reductions in perinatal HIV
transmission risk [8–10]. These improvements have transformed the reproductive health
landscape for people living with or affected by HIV [11–17], with studies demonstrating that
WLWH are more likely to become pregnant and have children in the modern cART era than
in earlier years of the HIV epidemic [18, 19].
Among WLWH in Canada, cART use is associated with increased fertility intention and an
increase in the proportion of WLWH becoming pregnant over time [12]; a finding that has
been corroborated in other settings [15, 18–23]. However, it is unknown whether such
increases in pregnancy incidence are driven by intended or unintended pregnancies [13, 15,
24–26], raising questions about how women’s reproductive health and agency are prioritized
and supported after an HIV diagnosis.
Supporting WLWH to plan for desired pregnancy and prevent unintended pregnancy is a
critical component of comprehensive women-centred HIV care [27] and central to women’s
sexual and reproductive health and rights and HIV prevention efforts [8, 28–32]. Unintended
pregnancies have numerous potential health implications including, higher risks of maternal
and infant morbidity and mortality, delayed engagement in antenatal care, poorer birth out-
comes, and poorer retention in postpartum follow-up [33]. Such risks are exacerbated for
WLWH, for whom early engagement in pre-conception, antenatal, and postpartum care is key
to maximizing maternal health and minimizing risks of perinatal transmission [34]. A preg-
nancy after an HIV diagnosis can be a stressful time, with women expressing significant worry
and fear about HIV-related concerns (i.e., their own health and the health of their infant) as
well as non HIV-related concerns (i.e., financial and relationship stress), coupled with experi-
ences of internalized and experienced HIV-related stigma around becoming pregnant [35, 36].
Determining the contribution of unintended pregnancy to the overall incidence of pregnancy
among WLWH is a key step towards the development of comprehensive reproductive rights-
and evidence-based programming across the continuum of reproductive care including pre-
conception care when pregnancy is intended, contraceptive access when it’s not, and the avail-
ability of safe termination services.
Pregnancy incidence by intention among women with HIV
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The primary objective of this study was to measure cumulative incidence and incidence
rate of pregnancy after HIV diagnosis among a cohort of WLWH in Canada overall and by
pregnancy intention, cART use status at time of pregnancy, and cART era (before or after the
year 2000). Our secondary objective was to determine independent socio-demographic and
clinical correlates of unintended pregnancy among the most recent or current pregnancy. This
information is key to the provision of targeted and tailored reproductive health services for
WLWH, to mitigate health risks, support reproductive rights, and focus prevention efforts
more effectively.
Methods
Study setting
As of 2011, there were approximately 16,600 WLWH in Canada, an increase of nearly 13%
from three years prior [37]. The majority of WLWH reside in the three Canadian provinces of
British Columbia, Ontario and Quebec. HIV prevalence and incidence are inequitably distrib-
uted among women in Canada along several social axes, including poverty, Indigenous ances-
try, injection drug use and/or sex work histories, refugee and newcomer status, African,
Caribbean, or Black Canadian (ACB) ethnicity, and sexual and gender identities, with several
points of intersection between and within these groups [37].
Study design and guiding frameworks
This analysis used baseline questionnaire data from the Canadian HIV Women’s Sexual and
Reproductive Health Cohort Study (CHIWOS), a multi-site, community-based research study
conducted by, with, and for WLWH in collaboration with researchers, healthcare providers,
policy-makers, and other stakeholders. As described in detail elsewhere [27, 38], the primary
objectives of CHIWOS are to assess the prevalence, barriers, and facilitators to use of women-
centred HIV care, and the impact of such patterns of use on health outcomes. CHIWOS is
grounded in community-based research principles [39], and guided by Social Determinants of
Health [40, 41] and Critical Feminism [42] frameworks, with the aim of producing commu-
nity-driven research and action on health priorities for WLWH.
Study population, recruitment, and procedures
Eligible participants included WLWH (self-identified) aged16 years, including trans and
gender diverse women, residing in British Columbia, Ontario, and Quebec. Between August
27, 2013 and May 1, 2015, women were recruited to participate in CHIWOS through peer
word-of-mouth, HIV clinics, AIDS Service Organizations, non-HIV community-based orga-
nizations, the networks of our national Steering Committee and three provincial Community
Advisory Boards, and online methods such as listservs for WLHIV and our study’s website
(www.chiwos.ca), Facebook (www.facebook.com/CHIWOS), and Twitter (www.twitter.com/
CHIWOSresearch) pages [43]. At enrolment, participants completed structured, comprehen-
sive questionnaires in English or French using online FluidSurveys™ software [44], adminis-
tered by Peer Research Associates, who are WLWH who completed training in community-
based research methods [45]. Study visits took 1.5 to 2.5 hours and were completed either in-
person at collaborating HIV clinics, AIDS Service Organizations, or women’s homes, or via
phone/Skype for those living in rural and remote areas. Follow-up interviews at 18-month
intervals are in-progress.
Participants provided voluntary, informed consent either by signing a consent form or, if
questionnaires were completed remotely, via verbal consent with a witness. Ethical approval
Pregnancy incidence by intention among women with HIV
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for this study was obtained from the Research Ethics Boards of Simon Fraser University, Uni-
versity of British Columbia/Providence Health, Women’s College Hospital, and McGill Uni-
versity Health Centre.
Analytic sample: Inclusion and exclusion criteria
A total of 1,424 WLHIV enrolled in the CHIWOS study and completed the baseline visit. Base-
line questionnaire data were used for this analysis including reports of lifetime history of preg-
nancy (up to eight pregnancy events in a lifetime). For this analysis, we excluded participants
who did not identify their biological sex as female (n = 57), women aged 45 or older at HIV
diagnosis (n = 139), women who reported completing menopause before HIV diagnosis
(n = 16), and women with unknown HIV diagnosis year (n = 47), yielding an analytic sample
of 1,165 women. We further restricted pregnancy incidence analyses to women who were diag-
nosed with HIV prior to date of pregnancy (estimated at conception). For pregnancy incidence
analyses and time-to-event calculations, we also excluded 19 participants missing pregnancy
dates and 10 who reported a pregnancy end date that was the same as the HIV diagnosis date.
These exclusions yielded an analytic sample of 1,136 women. Finally, for the analysis of corre-
lates of unintended pregnancy, we restricted the analysis to the most recent or current preg-
nancy reported after HIV diagnosis.
Measures
Primary outcome: Pregnancy incidence after HIV diagnosis. We assessed total number
of lifetime pregnancies and detailed retrospective event-level data for all reported pregnancies,
up to a maximum of eight lifetime pregnancies. The primary outcome was all self-reported
pregnancy events occurring after HIV diagnosis until censored (CHIWOS interview date),
including current pregnancies. For each pregnancy event reported after HIV diagnosis, data
were captured on pregnancy outcome (single live birth, multiple live births, miscarriage, still
birth, pregnancy termination, or ectopic pregnancy), pregnancy intention (unintended vs.
intended vs. don’t know), HIV status of the other biological parent (HIV positive vs. HIV neg-
ative vs. unknown), on cART before pregnancy occurred (yes vs. no), date of pregnancy out-
come (month and year), duration of pregnancy, and, if applicable, infant HIV status (HIV-
positive, HIV-negative, testing underway, or unknown). We estimated date of conception by
subtracting the duration of pregnancy from the date of pregnancy outcome.
To assess the pregnancy incidence rate, we applied the following rules to calculate woman-
years (WY) ‘at risk’ for pregnancy: (1) Time of follow-up began at reported HIV diagnosis date
or at 16 years of age, whichever date was later to avoid biasing time at risk among perinatally
infected women and (2) Women were censored at age 45, date of surgically induced meno-
pause (hysterectomy), or date of CHIWOS interview, whichever occurred first.
For analyses focused on the most recent or current pregnancy, we assessed additional infor-
mation regarding the pregnancy experience, including ‘feeling when found out about the cur-
rent or most recent pregnancy’ (very happy/happy vs. not sure/unhappy/very unhappy vs.
unknown), ‘happiness during current or most recent pregnancy’ (happiest time/happy time vs.
moderately hard/hard/worst times vs. unknown) [46]. Considering these additional data, we
only captured most recent or current pregnancy in the bivariate and multivariable analyses.
Explanatory variables. We examined associations of pregnancy incidence after HIV diag-
nosis and unintended pregnancy with baseline variables, identified a priori from the estab-
lished literature [11, 12, 20, 23, 25, 26]. Socio-demographic variables included: age at interview
[median and interquartile range (IQR)], province of interview (British Columbia vs. Ontario
vs. Quebec), ethnicity (Indigenous vs. African/Caribbean/Black vs. White vs. other ethnicities),
Pregnancy incidence by intention among women with HIV
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whether the participant was born in Canada (yes vs. no), legal relationship status at interview
(married/common-law vs. single), sexual orientation [heterosexual vs. lesbian, gay, bisexual,
two-spirit or queer (LGBTQ)], education (<high school vs.high school), annual personal
income at interview (<$20,000 vs.$20,000 per year), history of injection drug use (yes vs.
no) and history of incarceration (yes vs. no).
Health-related variables included Hepatitis C (HCV) co-infection (yes vs. no) and lifetime
diagnosis of any mental health condition (yes vs. no). HIV clinical variables included current
cART use (current use vs. previous use vs. never) and years living with HIV at interview. We
defined cART initiation era as ‘before the year 2000’ or ‘2000 or later’ as this is a general mark
of when therapy guidelines shifted to include evidence on the benefits of cART [47, 48].
Statistical analysis
For the primary objective, we assessed baseline characteristics of the sample of 1,165 WLWH
including pregnancy event information, demographics, and HIV diagnosis information. We
used Kaplan-Meier (K-M) methods to estimate cumulative incidence of time to first pregnancy
after HIV diagnosis or age 16 (whichever came later) to CHIWOS interview date. Overall
cumulative incidence of first pregnancy after HIV diagnosis was calculated as well as by
reported pregnancy intention (intended vs. unintended), by cART status (on cART vs. not on
cART prior to the start of pregnancy), and by cART era (prior to the year 2000 vs. the year
2000 until 2015). Log-rank test assessed statistical differences in the K-M curves.
Generalized estimating equation (GEE) Poisson models were used to calculate pregnancy
incidence rates expressed as incidence rate per 1,000 women-years (WY) with 95% confidence
intervals overall, by pregnancy intention, and cART status.
For the secondary objective, baseline characteristics of study participants were compared
for women with reported recent or current pregnancy by pregnancy intention, using Pearson
χ2 test or Fisher’s exact test for categorical variables and Wilcoxon’s Rank Sum test for contin-
uous variables. Multivariable logistic regression was used to identify independent correlates of
unintended pregnancy of the most recent or current pregnancy. Model selections were con-
ducted using a backward stepwise elimination technique based on two criteria (Akaike Infor-
mation Criterion (AIC) and Type III p-values).
Results
Baseline characteristics of study population
Among 1,165 WLWH included in the analysis, 30.1% identified as African/Caribbean/Black,
22.2% identified as Indigenous, 40.9% identified White and 6.8% as other ethnicities; 24.4%
were from British Columbia, 51.5% from Ontario, and 24.1% from Quebec. Our sample
included 12.2% LGBTQ women, 30.7% with a history of injection drug use, and 35.7% born
outside of Canada. Median age at interview was 41 (IQR: 35–48) and median years since HIV
diagnosis was 12 (IQR: 6–17).
Pregnancy incidence and outcomes
Among 1,165 WLWH, 278 (23.9%) women reported a total of 492 pregnancies after being
diagnosed with HIV, with 299 (60.8%) of those pregnancies reported as unintended. Of 492
pregnancies, 92 (18.7%) resulted in miscarriage or stillbirth, 101 (20.5%) were terminated,
and 282 (57.3%) resulted in a single or multiple live birth. Seventeen women (3.5%) were preg-
nant at time of interview. Among the 282 live births, 94.7% of infants tested HIV-negative
(Table 1). Among the sample of 1,165 WLWH, the median number of pregnancies from time
Pregnancy incidence by intention among women with HIV
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of HIV diagnosis until interview, including miscarriage, terminations and current pregnan-
cies, was 2 (IQR: 1–4) and the median number of children was 1 (IQR: 0–3). Of the pregnan-
cies occurring after HIV diagnosis, the median age at conception was 30 years [IQR: 25–34]
and in 328 (66.7%) of pregnancies, women had initiated cART prior to the start of pregnancy.
Using a further restricted sample of 1,136 with HIV diagnosis and pregnancy dates pro-
vided, we identified that by 1, 5, 10, and 20 years post HIV diagnosis, the cumulative probabil-
ity of first pregnancy after HIV diagnosis was 3%, 17%, 27% and 32%, respectively (Fig 1).
Unintended pregnancy (vs. intended) was cumulatively higher over time; with K-M curves
diverging at 1-year post HIV diagnosis (2.4% vs. 0.9%, p = 0.007), at 5 years post HIV diagnosis
(11.4% vs. 6.5%, p<0.001), and at 10 years post HIV diagnosis (16.8% vs 11.7%, p = 0.001) (Fig
2). At the 20-year mark after HIV diagnosis, the cumulative incidence of first pregnancy for
those with unintended pregnancy was 19.2% (95% CI: 16.2%-22.6%) compared to pregnancy
incidence among those with intended pregnancy of 14.6% (95% CI: 11.8%-18.0%). Women on
cART prior to pregnancy had higher probability of pregnancy over time; with K-M curves
diverging at 5 years post HIV diagnosis (10.9% vs. 6.9%, p = 0.004) and at 10 years post HIV
diagnosis (19.3% vs. 8.9%, p<0.001) (Fig 3). At the 20-year mark post HIV diagnosis, the
cumulative incidence of first pregnancy for those on cART was 23.8% (95% CI: 20.4%-27.8%)
compared to pregnancy incidence among those not on cART at time of pregnancy with preva-
lence of 9.2% (95% CI: 7.4%-11.6%). Lastly, while there was no difference at the 1- or 5-year
mark, women who initiated cART before the year 2000 had a significantly lower probability
of pregnancy at the 10-year and 20-year mark. At the 20-year mark post HIV diagnosis, the
cumulative incidence of first pregnancy for those who initiated cART before the year 2000 was
Table 1. Pregnancy events and outcomes after HIV diagnosis among 278 women living with HIV enrolled in the Canadian HIV women sexual and
reproductive health cohort study (CHIWOS), n = 492.
Variable Response n %
Age at conception (n = 441) (median) 30 (IQR) 25–34
Currently pregnant Yes 17 3.5%
Pregnancy intention
Intended pregnancy 189 38.4%
Unintended pregnancy 299 60.8%
Other* <5 <1%
Pregnancy outcome
Single or multiple live birth 282 57.3%
Miscarriage, Stillbirth, or Ectopic pregnancy 92 18.7%
Pregnancy termination 101 20.5%
On ART prior to pregnancy
Yes 328 66.7%
No 154 31.3%
Other* 10 2.0%
HIV test result of baby (live births, n = 282)
HIV positive <5 <1%
HIV negative 267 94.7%
Testing underway <5 <1%
Unknown 8 2.8%
*Other = unknown or prefer not to answer;
ART, antiretroviral therapy; IQR, interquartile range
https://doi.org/10.1371/journal.pone.0180524.t001
Pregnancy incidence by intention among women with HIV
PLOS ONE | https://doi.org/10.1371/journal.pone.0180524 July 20, 2017 6 / 19
26.7% (95% CI: 21.1%-33.5%) compared to those initiated therapy in the year 2000 or later
(39.2% [95%CI: 33.8%-45.1%]) (Fig 4).
After excluding pregnancies with unknown delivery/termination date, 256/1,146 women
reported 423 pregnancies after HIV diagnosis (incidence = 41.6 per 1,000 WYs; 95% CI: 36.6–
47.2) over 10,172.5 WYs of follow-up (Table 2). Incidence of unintended pregnancy (24.6 per
1,000 WYs; 95% CI: 21.0–28.7) was significantly higher than the incidence of intended preg-
nancy (16.6 per 1,000 WYs; 95% CI: 13.8–20.1) after HIV diagnosis. By cART use, pregnancy
incidence among WLWH on cART before or during pregnancy (29.1 per 1000 WYs; 95% CI:
25.1–33.8) was significantly higher than the pregnancy incidence among WLWH not on cART
during pregnancy (11.9 per 1000 WYs; 95% CI: 9.5–14.9).
Correlates of most recent/current pregnancy after HIV diagnosis
Of the 265 most recent or current pregnancies, 110 (41.5%) were intended and 155 (58.5%)
were unintended (Table 3), with only 62 (23.4%) pregnancies occurring prior to the year 2000
(pre-cART era). Women who reported their recent/current pregnancy as unintended com-
pared to intended, were significantly (p<0.05) more likely to identify as Indigenous (vs White)
Fig 1. Time to first pregnancy after HIV diagnosis. This figure demonstrates the estimated time to first
pregnancy event (inclusive of live births, terminations and miscarriages/stillbirths) for all women living with HIV in
our sample that provided HIV diagnosis date and estimated date of pregnancy (n = 1,136). This figure
demonstrates the cumulative incidence estimates and 95% confidence intervals at 1-, 5-, 10-, and 20-years for
any pregnancy event.
https://doi.org/10.1371/journal.pone.0180524.g001
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(20.0% vs. 11.8%), born in Canada (63.9% vs. 39.1%), be currently single (60.0% vs. 45.5%), co-
infected with HCV (38.7% vs. 21.8%), have a history of incarceration (45.8% vs. 26.4%), have a
history of injection drug use (38.7% vs. 23.6%), initiated ART before the year 2000 (29.0% vs.
15.5%), and to report having been previously diagnosed with a mental health disorder (inclu-
sive of depression, anxiety, post-traumatic stress disorder and addiction) (49.0% vs. 32.7%).
With respect to pregnancy experiences, women with an unintended vs. intended recent/
current pregnancy were more likely to report feeling unhappy about the referent pregnancy
(56.1% vs. 7.3%) and identifying the pregnancy experience as ‘one of the worst times of [her]
life’ (60.0% vs. 16.4%). Women who reported a recent/current pregnancy as unintended vs.
intended were also more likely to report pregnancy termination (28.4% vs. 1.8%).
In multivariable analyses (Table 4), factors independently associated with a most recent/
current unintended pregnancy included being currently single (AOR: 1.94, 95% CI: 1.10,
Fig 2. Time to first pregnancy after HIV diagnosis by intention status. This figure demonstrates the estimated
time to first pregnancy event (inclusive of live births, terminations and miscarriages/stillbirths) for all women living
with HIV in our sample that provided HIV diagnosis date and estimated date of pregnancy (n = 1,136). These
pregnancies are stratified by self-reported intention as either intended or unintended pregnancy. This figure
demonstrates the cumulative incidence estimates and 95% confidence intervals at 1-, 5-, 10-, and 20-years for
unintended and intended pregnancies.
https://doi.org/10.1371/journal.pone.0180524.g002
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3.42), being younger at time of pregnancy (AOR: 0.95 per year increase, 95% CI: 0.90, 0.99),
and being born in Canada (vs outside of Canada) (AOR: 2.76, 95% CI: 1.55, 4.92).
Discussion
Among women living with HIV in Canada, we found that approximately one in four women
reported pregnancy after HIV diagnosis and that pregnancy was more frequent in the modern
cART era and with uptake of cART. Pregnancy incidence rates observed in this study are
lower than rates observed in other studies of WLWH in other global settings [11, 15, 49, 50],
Fig 3. Time to first pregnancy after HIV diagnosis by cART status prior to pregnancy. This figure
demonstrates the estimated time to first pregnancy event (inclusive of live births, terminations and miscarriages/
stillbirths) for all women living with HIV in our sample that provided HIV diagnosis date and estimated date of
pregnancy (n = 1,136). These pregnancies are stratified by self-reported uptake of cART prior to the start of
pregnancy. This figure demonstrates the cumulative incidence estimates and 95% confidence intervals at 1-, 5-,
10-, and 20-years for pregnancies cART exposed and those pregnancies not exposed to cART.
https://doi.org/10.1371/journal.pone.0180524.g003
Pregnancy incidence by intention among women with HIV
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however is consistent with a lower pregnancy rate in the general Canadian population (54.6
per 1000 women) [51].
Approximately 60% of pregnancies after HIV diagnosis among women in this study were
reported as unintended and the prevalence varied by key socio-demographic characteristics.
The high observed prevalence of unintended pregnancy is consistent with estimates from a
cohort of WLWH in Ontario, where 57% of women reported that their most recent pregnancy
was unplanned [12] and comparable to the high rates of unintended pregnancies observed
among WLWH in other high-resource settings [52, 53]. Research conducted in Sub-Saharan
Africa, including Botswana and South Africa demonstrate that 37% to 69% of pregnancies
among WLWH are unintended [20, 54–56]. In the United States, approximately 69% of a total
of 620 pregnancy events among a sample of WLWH from 26 different regions were deter-
mined to be unplanned [53].
Fig 4. Time to first pregnancy after HIV diagnosis by era of cART initiation. This figure demonstrates the
estimated time to first pregnancy event (inclusive of live births, terminations and miscarriages/stillbirths) for all
women living with HIV in our sample that provided HIV diagnosis date and estimated date of pregnancy
(n = 1,136). These pregnancies are stratified by self-reported date of cART initiation (prior to the year 2000 vs the
year 2000 or later). This figure demonstrates the cumulative incidence estimates and 95% confidence intervals at
1-, 5-, 10-, and 20-years for all pregnancies by cART era.
https://doi.org/10.1371/journal.pone.0180524.g004
Pregnancy incidence by intention among women with HIV
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This study is the first of its kind to look at the impact of cART uptake and pregnancy rates
among WLWH in Canada. After decades of declining numbers of women becoming pregnant
after their HIV diagnosis [29, 36], we observed that WLWH on cART are more likely to
become pregnant compared to those not on cART prior to pregnancy, with incidence rates
nearly three times of that observed among WLWH not on cART. It must be noted that the
majority of pregnancy events in our sample (86.5%) occurred after the year 2000, and these
WLWH were more likely to become pregnant, and sooner after HIV diagnosis, compared to
women in the earlier treatment era. It is important to note that while a previous Canadian
study found no association between use of cART and fertility intentions, our study shows an
association between cART use and pregnancy events, further highlighting the importance of
addressing unintended pregnancy rates for all WLWH [17].
Previous studies have shown increases in pregnancy incidence after cART initiation [15, 20,
23, 57]. Observed increases in pregnancies for WLWH on cART are likely due to a combina-
tion of behavioural and biological factors including, increased life expectancy, increase in sex-
ual activity, and improved health and fertility status [31, 58, 59]. While some research has
stated that uptake of cART may improve engagement in care and thus increase uptake of con-
traceptives [60], our data suggests that a gap in family planning specific to WLWH exists given
that 60% of pregnancies are considered unintended. Our data indicate that pregnancy is more
common with cART uptake and current trends suggest future increases, although the role of
contraceptive uptake will need to be more thoroughly investigated. While we did not capture
lifetime contraceptive use patterns, data on contraceptive use at baseline among sexually active
women enrolled in CHIWOS reveal that 27.4% had not used an effective contraceptive method
in the previous six months [61]. Among those women who did report using contraception,
nearly half relied on the male condom [61]. This emerging work, as well as our finding around
the high prevalence of unintended pregnancy, underscores the need for improved integration
of family planning care as part of comprehensive HIV care for women [11, 62, 63].
Our study suggests that more than half of pregnancies among WLWH are unintended simi-
lar to rates observed in other studies of WLWH, which range from 51–90% [32, 34]. Such rates
are significantly higher than recent estimates among Canadian women of reproductive age in
the general population, among whom an estimated 27% of pregnancies are unintended [64].
Pregnancy termination occurred in one in five pregnancies among WLWH in our sample.
Consistent with earlier findings, women in our sample were significantly more likely to termi-
nate an unintended pregnancies compared to a reported intended pregnancy [20, 31, 65].
There are several limitations to this study. Our analyses rely on data collected via question-
naire suggesting recall bias is likely present. The retrospective data collection on lifetime
Table 2. GEE Poisson model to calculate pregnancy incidence rates, expressed asnumber of pregnancies per 1000 woman-years (WY) (95% confi-
dence interval).
Pregnancy type Number of
observations
Incidence rate per 1000 WY (95% Confidence
Interval)
Rate Ratio (95% Confidence
interval)
Overall - 423 41.6 (36.6–47.2) -
Intention Intended 169 16.6 (13.8–20.1) 1.5 (1.2–1.8)*
Unintended 250 24.6 (21.0–28.7)
cART
status
On cART before
pregnancy
296 29.1 (25.1–33.8) 2.4 (2.0–3.0)*
Not on cART before
pregnancy
121 11.9 (9.5–14.9)
*Statistically significant at p<0.001
https://doi.org/10.1371/journal.pone.0180524.t002
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Table 3. Bivariate analysis for intended vs. unintended current or most recent pregnancy, among women living with HIV (n = 265).
Variable Response Intended pregnancy,
n = 110 (n, %)
Unintended pregnancy
n = 155 (n, %)
p-value
Province interview conducted
British Columbia 24 (21.8%) 46 (29.7%) 0.065
Ontario 44 (40.0%) 70 (45.2%)
Quebec 42 (38.2%) 39 (25.2%)
Ethnicity
Indigenous 13 (11.8%) 31 (20.0%) 0.004
African/Caribbean/Black 57 (51.8%) 48 (31.0%)
White 32 (29.1%) 67 (43.2%)
Other ethnicities 8 (7.3%) 9 (5.8%)
Born in Canada
Yes 43 (39.1%) 99 (63.9%) <0.001
No 67 (60.9%) 56 (36.1%)
Current legal relationship status
Married/Common-law/In a relationship 60 (54.6%) 62 (40.0%) 0.019
Single/Separated/Divorced/Widow/Other
relationship status
50 (45.5%) 93 (60.0%)
Sexual orientation
Heterosexual 103 (93.6%) 134 (86.5%) 0.061
LGBTQ 7 (6.4%) 21 (13.6%)
HCV co-infection
Yes 24 (21.8%) 60 (38.7%) 0.004
No 86 (78.2%) 95 (61.3%)
Diagnosis of mental health condition
by care provider
Yes 36 (32.7%) 76 (49.0%) 0.01
No 71 (64.5%) 77 (49.7%)
Other+ * *
History of injection drug use
Yes 26 (23.6%) 60 (38.7%) 0.009
No 84 (76.4%) 94 (60.7%)
Other+ 0 (0) *
Era of cART initiation
Before Year 2000 17 (15.5%) 45 (29.0%) 0.014
Year 2000 or after 81 (73.6%) 98 (63.2%)
Other+ 12 (10.9%) 12 (7.7%)
Years living with HIV, at interview
Less than 6 years 16 (14.5%) 16 (10.3%) 0.277
6 to 14 years 57 (51.8%) 73 (47.1%)
More than 14 years 37 (33.6%) 66 (42.6%)
Currently pregnant, at interview
Yes 8 (7.27%) 7 (4.5%) 0.342
No 101 (91.8%) 146 (94.2%)
Other + * *
Feeling when found out about
current/recent pregnancy
Very happy/happy to be pregnant 100 (90.9%) 67 (43.2%) <0.001
(Continued )
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Table 3. (Continued)
Variable Response Intended pregnancy,
n = 110 (n, %)
Unintended pregnancy
n = 155 (n, %)
p-value
Not sure/Unhappy/Very unhappy to be
pregnant
8 (7.3%) 87 (56.1%)
Other + * *
Time during the current/recent
pregnancy
One of the happiest times of my life/A happy
time with a few problems
91 (82.7%) 57 (36.8%) <0.001
A moderately hard/Very hard/Worst time 18 (16.4%) 93 (60.0%)
Other + * 5 (3.2%)
HIV status of the other biological
parent
HIV positive 36 (32.7%) 38 (24.5%) 0.016
HIV negative 63 (57.3%) 80 (51.6%)
Unknown HIV status 10 (9.1%) 34 (21.9%)
Other + * *
Intend to become pregnant in the
future
Yes 31 (28.2%) 30 (19.6%) 0.143
No 51 (46.4%) 78 (50.3%)
Other+ 28 (25.5%) 47 (30.3%)
On cART before pregnancy occurred
Yes 88 (80.0%) 117 (75.5%) 0.359
No 21 (19.1%) 37 (23.9%)
Other+ * *
Pregnancy outcome
Single/multiple live birth 83 (75.5%) 86 (55.5%) <0.001
Miscarriage/Stillbirth/Ectopic pregnancy 17 (15.5%) 18 (11.6%)
Pregnancy termination * 44 (28.4%)
Current pregnancy at interview^ 8 (7.3%) 7 (4.5%)
HIV test result of baby
HIV positive 0 (0) * 0.999
HIV negative 80 (72.7%) 81 (52.3%)
Testing underway * *
Other/No live birth 29 (26.4%) 71 (45.8%)
Median (IQR) Median P-
value
Age at interview date 38 (34–43) 37 (33–43) 0.674
Duration of HIV Diagnosis (in years) 12.0 (7.8–16.1) 13.2 (8.2–18.6) 0.146
Number of previous pregnancies 3 (2–4) 3 (2–5) 0.967
Age at conception (n = 255) 32 (29–36) 31 (27–35) 0.027
Number of years to first pregnancy
after HIV diagnosis
3.6 (1.5–6.1) 3.1 (1.2–5.1) 0.331
Notes: LGBTTQ, lesbian, gay, bisexual, trans, two-spirit or queer; cART, combination antiretroviral therapy
*Cells indicated where n<5 and excluded from p-value analysis
^ Excluded from p-value analysis
+Inclusive of don’t know, prefer not to answer, and other responses
https://doi.org/10.1371/journal.pone.0180524.t003
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history of pregnancy did not allow for an assessment of important behaviours prior to or dur-
ing pregnancy including contraceptive use at the time of each reported pregnancy, relationship
status, smoking, substance use and other socio-behavioural factors. Moreover, with a sensitive
outcome of interest being collected retrospectively, there may be some misclassification bias
due to shifting perceptions of pregnancy intention in relation to the subsequent outcome of
that pregnancy. However, research has suggested that retrospectively collecting data on preg-
nancy intention likely does not lead to misleading estimates of the prevalence of unintended
pregnancies [66], however this has not been validated in a context with WLWH where there
may still be significant stigma attached to becoming pregnant or intending to become preg-
nant. In an attempt to mitigate the influence of bias, questionnaires were administered by
trained peer research associates, who were also living with HIV, and were able to guide partici-
pants through their pregnancy history. The authors believe this may better support accurate
data collection (relative to self-administered or non-peer administered surveys). As well, par-
ticipants were aware that they were being interviewed by women who shared a lived experi-
ence of living with HIV, which likely reduced social desirability bias.
Our rates of pregnancy may be underestimating fertility rates of WLWH as our cohort is
older and may not represent all women who are currently living with HIV of reproductive age.
Moreover, post-menopausal women who were under 45 years of age were not appropriately
censored in this analysis since we had no date of spontaneous menopause As such, our at-risk
time may be inflated and our estimates of pregnancy incidence may be lower than actual rates.
Although we excluded 127 women who were 45 years old or older at the time of HIV diagno-
sis, censoring women at 45 was deliberately done to most accurately capture those likely to
Table 4. Univariate and Multivariable model of factors associated with unintended (vs intended) pregnancy for most recent or current pregnancy,
n = 265.
Variable Response Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (aOR) (95% CI)
Ethnicity
White Reference Not selected
Indigenous 1.14 (0.53, 2.47)
African/Caribbean/
Black
0.40 (0.23, 0.71)
Other ethnicities 0.54 (0.19, 1.52)
Born in Canada
No Reference Reference
Yes 2.75 (1.66, 4.56) 2.76 (1.55, 4.92)
Current legal relationship status
Married/Common-law Reference Reference
Single/Divorced/Widow 1.80 (1.098, 2.950) 1.94 (1.10, 3.42)
Diagnosis of mental health condition by care
provider
No Reference Reference
Yes 1.95 (1.17, 3.25) 1.53 (0.85, 2.75)
Age at conception, per one year increase (n = 255) 0.95 (0.90, 0.99) 0.95 (0.90, 0.99)
HIV status of the other parent
HIV-positive Reference Not selected
HIV-negative/unknown 1.48 (0.86, 2.55)
cART era
2000 Reference Not selected
<2000 2.19 (1.16, 4.11)
https://doi.org/10.1371/journal.pone.0180524.t004
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become pregnant. We found only fewer than 5 women in our sample over the age of 45 who
had pregnancy events after HIV diagnosis. In addition, we did not have detailed pregnancy
data after eight lifetime pregnancy events and 28 (2.4%) of WLWH in our sample reported
more than eight pregnancies. Despite these limitations, our study provides the most compre-
hensive picture of pregnancy incidence among WLWH in Canada with over 1400 participants
and on-going data collection that providing longitudinal data on sexual and reproductive
health outcomes among WLWH.
Given known risks of unintended pregnancy to maternal, partner, and perinatal health, our
findings underscore the need for comprehensive women-centered sexual and reproductive
health programming for WLWH, including provision of effective contraceptive options and
pregnancy planning support, and access to safe termination services. In the modern cART era,
WLWH must have access to comprehensive reproductive health care and support that extends
beyond concerns of sexual and perinatal HIV transmission. These changing reproductive
health patterns, including more WLWH becoming pregnant and a high prevalence of unin-
tended pregnancy, have significant implications for women’s overall well-being. Promotion of
reproductive health care, supporting women’s reproductive autonomy, decisions and desires,
and enhancing access to effective contraceptive options alongside safe, non-coercive preg-
nancy termination services should be available in conjunction with evolving HIV care and
improved therapeutic options for WLWH.
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